BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 32588948)

  • 1. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
    Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
    Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mesenchymal stem cells-derived exosomes on tumor microenvironment: Tumor progression versus tumor suppression.
    Shojaei S; Hashemi SM; Ghanbarian H; Salehi M; Mohammadi-Yeganeh S
    J Cell Physiol; 2019 Apr; 234(4):3394-3409. PubMed ID: 30362503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.
    Balaji S; Kim U; Muthukkaruppan V; Vanniarajan A
    Life Sci; 2021 Sep; 280():119750. PubMed ID: 34171378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex interplay between tumor microenvironment and cancer therapy.
    Shen M; Kang Y
    Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
    Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes: Critical Mediators of Tumour Microenvironment Reprogramming.
    Malla RR; Shailender G; Kamal MA
    Curr Med Chem; 2021; 28(39):8182-8202. PubMed ID: 33334279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response.
    Gilabert-Oriol R; Ryan GM; Leung AWY; Firmino NS; Bennewith KL; Bally MB
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Tumor Microenvironment for Cancer Therapy.
    Roma-Rodrigues C; Mendes R; Baptista PV; Fernandes AR
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
    Jena BC; Mandal M
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Glypican-1 in the Tumour Microenvironment.
    Lund ME; Campbell DH; Walsh BJ
    Adv Exp Med Biol; 2020; 1245():163-176. PubMed ID: 32266658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal niches of bone marrow in cancer.
    Abarrategi A; Marińas-Pardo L; Mirones I; Rincón E; García-Castro J
    Clin Transl Oncol; 2011 Sep; 13(9):611-6. PubMed ID: 21865132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance.
    Santos P; Almeida F
    Cells; 2020 Jun; 9(6):. PubMed ID: 32545155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
    Wu Q; Zhou L; Lv D; Zhu X; Tang H
    J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal Molecular Imaging of the Tumour Microenvironment.
    Foray C; Barca C; Backhaus P; Schelhaas S; Winkeler A; Viel T; Schäfers M; Grauer O; Jacobs AH; Zinnhardt B
    Adv Exp Med Biol; 2020; 1225():71-87. PubMed ID: 32030648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice.
    Lin WC; Lin YT; Chao HC; Lin YY; Hwang WL
    Clin Transl Med; 2023 Oct; 13(10):e1448. PubMed ID: 37830387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment.
    Whiteside TL
    Semin Immunol; 2018 Feb; 35():69-79. PubMed ID: 29289420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.